Cargando…
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response
BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) surveillance in low‐risk patients (annual incidence <1.5%) is not recommended per the American Association for the Study of Liver Diseases guidelines. Because patients with chronic hepatitis C with non‐advanced fibrosis who have achieved sustaine...
Autores principales: | Ishido, Shun, Tamaki, Nobuharu, Kurosaki, Masayuki, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Mashiba, Toshie, Ochi, Hironori, Yasui, Yutaka, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Fujii, Hideki, Ishii, Toru, Marusawa, Hiroyuki, Kondo, Masahiko, Kusakabe, Atsunori, Yoshida, Hideo, Uchida, Yasushi, Tada, Toshifumi, Nakamura, Shinichiro, Mitsuda, Akari, Ogawa, Chikara, Arai, Hirotaka, Murohisa, Toshimitsu, Uebayashi, Minoru, Izumi, Namiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290273/ https://www.ncbi.nlm.nih.gov/pubmed/37359109 http://dx.doi.org/10.1002/jgh3.12914 |
Ejemplares similares
-
Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection
por: Fujii, Hideki, et al.
Publicado: (2022) -
A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
por: Tada, Toshifumi, et al.
Publicado: (2021) -
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy
por: Tada, Toshifumi, et al.
Publicado: (2022) -
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
por: Kaneko, Shun, et al.
Publicado: (2020) -
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
por: Tamaki, Nobuharu, et al.
Publicado: (2021)